Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Payette

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Connecticut Medicine|May 9, 2018
The Unsustainable Cost of Medicaid: Insights from a Hospital-Based Academic Dermatology PracticeMichael J Payette
Dermatologic Therapy|October 6, 2018
Estimated cost efficacy of U.S. Food and Drug Administration-approved treatments for acneMichael Tassavor, Michael J Payette
Journal of the American Academy of Dermatology|January 30, 2015
Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasisLogan S D'Souza, Michael J Payette
JAAD Case Reports|May 26, 2017
Combination biologic therapy for the treatment of severe palmoplantar pustulosisKristin M Torre, Michael J Payette
International Journal of Dermatology|March 20, 2019
A peculiar dermatomal plaqueEdward Hochman, Katalin Ferenczi, Michael J Payette
Dermatology Online Journal|January 26, 2019
Tuberculosis and interleukin blocking monoclonal antibodies: Is there risk?Andrew Kelsey, Lisa M Chirch, Michael J Payette
JAAD Case Reports|November 15, 2023
A case of erythema annulare centrifugum cleared with upadacitinibValerie Foy, Meagen M McCusker, Michael J Payette
Clinics in Dermatology|November 2, 2010
Nutrition and nonmelanoma skin cancersMichael J Payette, James Whalen, Jane M Grant-Kels
Clinics in Dermatology|December 20, 2008
Melanoma prognostic factors found in the dermatopathology reportMichael J Payette, Marilyn Katz, Jane M Grant-Kels
Journal of the American Academy of Dermatology|October 12, 2019
Hidradenitis suppurativa: Current and emerging treatmentsSamantha R Goldburg, Bruce E Strober, Michael J Payette
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Connecticut Medicine|May 9, 2018
The Unsustainable Cost of Medicaid: Insights from a Hospital-Based Academic Dermatology PracticeMichael J Payette
Dermatologic Therapy|October 6, 2018
Estimated cost efficacy of U.S. Food and Drug Administration-approved treatments for acneMichael Tassavor, Michael J Payette
Journal of the American Academy of Dermatology|January 30, 2015
Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasisLogan S D'Souza, Michael J Payette
JAAD Case Reports|May 26, 2017
Combination biologic therapy for the treatment of severe palmoplantar pustulosisKristin M Torre, Michael J Payette
International Journal of Dermatology|March 20, 2019
A peculiar dermatomal plaqueEdward Hochman, Katalin Ferenczi, Michael J Payette
Dermatology Online Journal|January 26, 2019
Tuberculosis and interleukin blocking monoclonal antibodies: Is there risk?Andrew Kelsey, Lisa M Chirch, Michael J Payette
JAAD Case Reports|November 15, 2023
A case of erythema annulare centrifugum cleared with upadacitinibValerie Foy, Meagen M McCusker, Michael J Payette
Clinics in Dermatology|November 2, 2010
Nutrition and nonmelanoma skin cancersMichael J Payette, James Whalen, Jane M Grant-Kels
Clinics in Dermatology|December 20, 2008
Melanoma prognostic factors found in the dermatopathology reportMichael J Payette, Marilyn Katz, Jane M Grant-Kels
Journal of the American Academy of Dermatology|October 12, 2019
Hidradenitis suppurativa: Current and emerging treatmentsSamantha R Goldburg, Bruce E Strober, Michael J Payette
Pageof 2